Neutralization effects of interleukin-6 (IL-6) antibodies on sulfur mustard (HD)-induced IL-6 secretion on human epidermal keratinocytes

Environmental Toxicology and Pharmacology

Volumn 17, Issue 2, 2004, Pages 87-94

  Arroyo, Carmen M ^a   Burman, Damon L ^a,b   Sweeney, Richard E ^a,c   Broomfield, Clarence A ^a   Ross, Michelle C ^a   Hackley Jr , Brennie E ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c RESECO   (United States)

Author keywords

Anti IL 6 antibodies; HD; Human interleukin 6; Human skin cells; Immunocytologic assay; Keratinocytes; RT PCR; Sulfur mustard

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; MUSTARD GAS; RNA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INCUBATION TIME; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 2942607579     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2004.03.004     Document Type: Article

References (25)

1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1
2. Arroyo C.M., Schafer R.J., Kurt E.M., Broomfield C.A., Carmichael A.J. Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure. Hum. Exp. Toxicol. 18:1999;1
3. Arroyo C.M., Broomfield C.A., Hackley B.E. Jr. The role of interleukin (IL-6) in human sulfur (HD) toxicology. Int. J. Toxicol. 20:2001;281
4. 3 on interleukin 6 and 8 secretion induced by sulfur mustard (HD) on human skin cells. Pharmacol. Toxicol. 92:2003;204
5. Beck J.T., Su-Ming H., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N. Engl. J. Med. 330:1994;602
6. Boyce S.T., Ham R.G. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media. J. Tiss. Cult. Methods. 9:1985;83
7. Byrne M.P., Broomfield C.A., Stites W.E. Mustard gas crosslinking of protein through preferential alkylation of cysteines. J. Protein Chem. 15(2):1996;131-136
8. de Hon F.D., Boekel E.T., Herrman J. Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130. Cytokine. 7:1995;398
9. Gross C.L., Giles K.C., Smith W.J. L-oxothiazolidine 4-carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxicity. Cell Biol. Toxicol. 13:1997;167
10. Guzman, J.J., Kelly, S.A, Gross, C.L., Smith, W.J., 2000. In vitro cytotoxicity assay of human epidermal keratinocytes in culture exposed to sulfur mustard. Technical Report USAMRICD-TR-00-03, US Army Medical Research Institute of Chemical Defense, AD A385183, Aberdeen Proving Ground, MD, USA.
11. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response (review article). Biochem. J. 265:1990;621
12. Kelso A. Cytokines: principles and prospects. Immunol. Cell Biol. 76:1998;300
13. Klein B., Wijdenes J., Zhang X.G., Jourdan M., Boiron J.M., Brochier J., Liautard J., Merlin M., Clement C., Morel-Fournier B., Lu Z.Y., Mannoni P., Sany J., Bataille R. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 78:1991;1198
14. Kupper T.S., Min K., Sehgal P., Mizutani H., Birchall N., Ray A., May L. Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity. Ann. N. Y. Acad. Sci. 557:1989;454
15. Martin, Y.C., 1978. Quantitative Drug Design (Medical Research). Marcel Dekker, New York, p. 115.
16. Papirmeister, B., Feister, A.J., Robinson, S.I., Ford, R.D., 1991. Medical Defense against Mustard Gas. Toxic Mechanisms and Pharmacological Implications. CRC Press, Boca Raton, FL.
17. Rock F.L., Li X., Chong P., Ida N., Klein M. Roles of disulfides bonds in recombinant human interleukin-6 conformatio. Biochemistry. 33:1994;5146
18. Rhodes L.S., Hahim I.A., Mclaughlin P.J., Friedmann P.S. Blister fluid cytokine in cutaneous inflammatory bullous disorders. Acta Derm. Venereol. 79:1999;288
19. Ryan, T.P., 1989. Statistical Methods for Quality Improvement. Wiley, New York.
20. Sawamura D., Meng X., Ina S., Tamai K., Hanada K., Hashimoto I. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. J. Immunol. 161:1998;5633
21. Sidell, F.R., Urbanetti, J.S., Smith, W.J., Hurst, C.G., 1997. Vesicants. In: Sidell, F.R., Takafuji, E.T., Franz, D.R. (Eds.), Medical Aspects of Chemical and Biological Warfare. Part I. Warfare, Weaponry, and the Casualty. Office of the Surgeon General, TMM Publications, Washington, DC.
22. Taga, T., Kuhimoto, T., 1990. IL-6 receptor. In: Cochrane, C.C., Gimbrone Jr., M.A. (Eds.), Cellular and Molecular Mechanisms of Inflammation. Academic Press, New York, p. 29.
23. Taylor, J.D., Briley, D., Nguyen, Q., Long, K., Iannone, M.A., Li, M.S., Ye, F., Afshari, A., Lai, E., Wagner, M., Chen, J., Weiner, M.P., 2001. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 30, 661, 668.
24. Van Snick J. Interleukin-6: an overview. Ann. Rev. Immunol. 8:1990;253
25. Vogt R.F. Jr., Dannenberg A.M. Jr., Schofield B.H., Hynes N.A., Papirmeister B. Pathogenesis of skin lesions caused by sulfur mustard. Fundam. Appl. Toxicol. 4:1984;S71